Principal Investigator-
2013 -A Randomized, Double-blind, Placebo controlled, Phase 3 Study to Assess the Efficacy and Safety of AMG 416 in the Treatment of Secondary Hyperparathyroidism in Subjects with Chronic Kidney
Disease on Hemodialysis.
Principal Investigator-
2011 -A Randomized, Double-blinded, Placebo Controlled, phase Ill study of Dialysate containing soluble ferric Pyrophosphate (SFP) in Chronic Kidney Disease patients receiving hemodialysis: The Continuous Replacement Using Iron Soluble Equivalents (CRUISE) study.
Principal Investigator-
2011 -A prospective, multicenter, randomized, evaluator-blinded, comparator-controlled study to describe the safety and efficacy of Daptomycin for the treatment of complicated skin and skin structure infections (cSSSI) and staphylococcus aureus bacteremia among subjects with moderate or severe renal impairment (DAP-RENSE-08-05)
Principal Investigator-
2008-outcome trial evaluation the efficacy and safety of Norditropin in adult patients on Chronic Hemodialysis. A randomized, double -blind, parallel group, placebo controlled, multi- center trial Principal Investigator- 2007 -A phase 3 randomized, active -controlled, open label, multi- center study of the safety and efficacy of AF37702 injection for the maintenance treatment of Anemia in hemodialysis patients previously treated with Epoetin Alfa.
Principal Investigator-
2007- A phase IV, long term observational safety study in ESRD subjects treated with Lanthanium Carbonate
Principal Investigator-
2005-A phase IV open label, multi- center Trial evaluating the efficacy of FOSRENOL compared to existing therapy in adults with ESRD treated for hyperphosphatemia.
Principal Investigator-
2004 - The treatment of Anemia with Aranesp (ST AAR) Study
Principal Investigator-
2002 -A multi -center study using once every other week subcut administration of Aranesp and Iron guided Algorithms to treat subjects with Anemia of Chronic Renal insufficiency
Principal Investigator-
2000 - A multi - center study using once every other week subcut administration of Erythropoetin (Procrit- Orthobiotec) to treat subjects with Anemia of Chronic Renal insufficiency